Ticker

Vancouver, British Columbia – TheNewswire - March 18, 2026 – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has completed its previously announced non-brokered private placement and issued  9,625,049 units (each, a “ Unit ”) at a price of $0.24 per Unit for gross proceeds of $2,310,011.76 (the “ Offering ”). Each Unit consists of: (i) one common…

Vancouver, British Columbia, March 16, 2026 – TheNewswire - At the request of CIRO, Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. The Company is a biotechnology company focused on discovering and developing…

VANCOUVER, BC – TheNewswire - March 13, 202 6 – Noveris Health Sciences Inc. ( CSE: NVRS ) ( FSE: 0NF0 ) ( OTC: MYCOF ) (the " Company ") is pleased to announce the launch of its new investor-facing website at http://noveris.health . The website has been developed to provide shareholders, prospective investors, and other stakeholders with timely access to corporate information, investor materials, and company…

Vancouver, British Columbia, March 10, 2026 – TheNewswire — Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today that Joshua Bartch has resigned as director, president and chief executive officer of the Company. The Company has appointed Jason Birmingham, who was previously appointed chief strategy officer on February 2, 2026, to assume all three positions formerly held…

Vancouver, British Columbia, March 6, 2026 — TheNewswire - Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today the conversion of debentures in the aggregate principal amount of $8,188,628 (the “ Debentures ”) resulting in the issuance of a total of 47,687,939 common shares of the Company, initiated at the option of the debenture holders.  The Debentures were originally…